Erythrocyte osmotic fragility and oxidative stress in experimental hypothyroidism

被引:20
作者
Dariyerli, N
Toplan, S
Akyolcu, MC
Hatemi, H
Yigit, G
机构
[1] Istanbul Univ, Cerrahpasa Med Fac, Dept Physiol, Istanbul, Turkey
[2] Istanbul Univ, Cerrahpasa Med Fac, Dept Biophys, Istanbul, Turkey
[3] Istanbul Univ, Cerrahpasa Med Fac, Dept Internal Med, Istanbul, Turkey
关键词
hypothyroid; erythrocyte osmotic fragility; oxidative stress;
D O I
10.1385/ENDO:25:1:01
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study was planned to explain the relation between erythrocyte osmotic fragility and oxidative stress and antioxidant statue in primary hypothyroid-induced experimental rats. Twenty-four Spraque Dawley type female rats were divided into two, as control (n = 12) and experimental (n = 12), groups weighing between 160 and 200 g. The experimental group animals have received tap water methimazole added standard fodder to block the iodine pumps for 30 d (75 mg/100 g). Control group animals were fed tap water and only standard fodder for the same period. At the end of 30 d blood samples were drawn from the abdominal aorta of the rats under ether anesthesia. T-3, T-4, and TSH levels were measured and the animals that had relatively lower T-3, T-4, and higher TSH levels were accepted as hypothyroid group. Hormone levels of the control group were at euthyroid conditions. Osmotic fragility, as a lipid peroxidation indicator malondialdehyde (MDA), antioxidant defense system indicators superoxide dismutase (SOD) and glutathione (GSH) levels were measured in the blood samples. Osmotic fragility test results: There was no statistically significant difference found between maximum osmotic hemolysis limit values of both group. Minimum osmotic hemolysis limit value of hypothyroid group was found to be higher than that of control group values (p < 0.02). The standard hemolysis and hemolytic increment curve of the hypothyroid group drawn according to osmotic fragility test results was found to be shifted to the right when compared to control group's curve. This situation and hemolytic increment value, which shows maximum hemolysis ratio, is the proof of increased osmotic fragility of the erythrocytes in hypothyroidism. There is no statistically significant difference found between hypothyroid and control groups in the lipid peroxidation indicator MDA and antioxidant indicators SOD and GSH levels. As a result of our study it may be concluded that hypothyroidism may lead to an increase in osmotic fragility of erythrocytes. But the increase in erythrocyte osmotic fragility does not originate from lipid peroxidation.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 29 条
[1]   Oxidative damage, plasma antioxidant capacity, and glucemic control in elderly NIDDM patients [J].
Aguirre, F ;
Martin, I ;
Grinspon, D ;
Ruiz, M ;
Hager, A ;
De Paoli, T ;
Ihlo, J ;
Farach, HA ;
Poole, CP .
FREE RADICAL BIOLOGY AND MEDICINE, 1998, 24 (04) :580-585
[2]  
ANDERSON ME, 1989, ENZYMATIC CHEM METHO, VA
[3]  
[Anonymous], 1985, OXIDATIVE STRESS
[4]  
Ansell Jack E., 1996, P821
[5]   LIPID-PEROXIDATION AND FREE-RADICAL SCAVENGERS IN THYROID-DYSFUNCTION IN THE RAT - A POSSIBLE MECHANISM OF INJURY TO HEART AND SKELETAL-MUSCLE IN HYPERTHYROIDISM [J].
ASAYAMA, K ;
DOBASHI, K ;
HAYASHIBE, H ;
MEGATA, Y ;
KATO, K .
ENDOCRINOLOGY, 1987, 121 (06) :2112-2118
[6]  
Bhattacharyya A D, 1994, J Assoc Physicians India, V42, P366
[7]   Erythrocyte osmotic fragility test as the measure of defence against free radicals in rabbits of different age [J].
Brzezinska-Slebodzinska, E .
ACTA VETERINARIA HUNGARICA, 2001, 49 (04) :413-419
[8]   Hyperuricemia in hypothyroidism:: Is it associated with post-insulin infusion glycemic response? [J].
Dariyerli, N ;
Andican, G ;
Çatakoglu, AB ;
Hatemi, H ;
Burçak, G .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 199 (02) :59-68
[9]   Lipid peroxidation, osmotic fragility and antioxidant status in children with acute post-streptococcal glomerulonephritis [J].
Devasena, T ;
Lalitha, S ;
Padma, K .
CLINICA CHIMICA ACTA, 2001, 308 (1-2) :155-161
[10]  
Dumitriu L, 1988, Endocrinologie, V26, P35